-
Something wrong with this record ?
Deterioration of mitochondrial bioenergetics and ultrastructure impairment in skeletal muscle of a transgenic minipig model in the early stages of Huntington's disease
M. Rodinova, J. Krizova, H. Stufkova, B. Bohuslavova, G. Askeland, Z. Dosoudilova, S. Juhas, J. Juhasova, Z. Ellederova, J. Zeman, L. Eide, J. Motlik, H. Hansikova,
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2011
Free Medical Journals
from 2008 to 6 months ago
Freely Accessible Science Journals
from 2008
PubMed Central
from 2008
Europe PubMed Central
from 2008
ProQuest Central
from 2008-01-01
Open Access Digital Library
from 2011-01-01
Health & Medicine (ProQuest)
from 2008-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2008
PubMed
31278192
DOI
10.1242/dmm.038737
Knihovny.cz E-resources
- MeSH
- DNA metabolism MeSH
- Energy Metabolism * MeSH
- Animals, Genetically Modified MeSH
- Huntington Disease metabolism pathology MeSH
- Muscle, Skeletal metabolism ultrastructure MeSH
- Humans MeSH
- Swine, Miniature MeSH
- Mitochondrial Proteins metabolism MeSH
- Disease Models, Animal * MeSH
- Mutation MeSH
- Oxidative Phosphorylation MeSH
- Swine MeSH
- Disease Progression MeSH
- Huntingtin Protein genetics MeSH
- Mitochondria, Muscle metabolism ultrastructure MeSH
- Body Weight MeSH
- Electron Transport MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Skeletal muscle wasting and atrophy is one of the more severe clinical impairments resulting from the progression of Huntington's disease (HD). Mitochondrial dysfunction may play a significant role in the etiology of HD, but the specific condition of mitochondria in muscle has not been widely studied during the development of HD. To determine the role of mitochondria in skeletal muscle during the early stages of HD, we analyzed quadriceps femoris muscle from 24-, 36-, 48- and 66-month-old transgenic minipigs that expressed the N-terminal portion of mutated human huntingtin protein (TgHD) and age-matched wild-type (WT) siblings. We found altered ultrastructure of TgHD muscle tissue and mitochondria. There was also significant reduction of activity of citrate synthase and respiratory chain complexes (RCCs) I, II and IV, decreased quantity of oligomycin-sensitivity conferring protein (OSCP) and the E2 subunit of pyruvate dehydrogenase (PDHE2), and differential expression of optic atrophy 1 protein (OPA1) and dynamin-related protein 1 (DRP1) in the skeletal muscle of TgHD minipigs. Statistical analysis identified several parameters that were dependent only on HD status and could therefore be used as potential biomarkers of disease progression. In particular, the reduction of biomarker RCCII subunit SDH30 quantity suggests that similar pathogenic mechanisms underlie disease progression in TgHD minipigs and HD patients. The perturbed biochemical phenotype was detectable in TgHD minipigs prior to the development of ultrastructural changes and locomotor impairment, which become evident at the age of 48 months. Mitochondrial disturbances may contribute to energetic depression in skeletal muscle in HD, which is in concordance with the mobility problems observed in this model.This article has an associated First Person interview with the first author of the paper.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20023808
- 003
- CZ-PrNML
- 005
- 20201214131257.0
- 007
- ta
- 008
- 201125s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1242/dmm.038737 $2 doi
- 035 __
- $a (PubMed)31278192
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Rodinova, Marie $u Laboratory for Study of Mitochondrial Disorders, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12108 Prague 2, Czech Republic.
- 245 10
- $a Deterioration of mitochondrial bioenergetics and ultrastructure impairment in skeletal muscle of a transgenic minipig model in the early stages of Huntington's disease / $c M. Rodinova, J. Krizova, H. Stufkova, B. Bohuslavova, G. Askeland, Z. Dosoudilova, S. Juhas, J. Juhasova, Z. Ellederova, J. Zeman, L. Eide, J. Motlik, H. Hansikova,
- 520 9_
- $a Skeletal muscle wasting and atrophy is one of the more severe clinical impairments resulting from the progression of Huntington's disease (HD). Mitochondrial dysfunction may play a significant role in the etiology of HD, but the specific condition of mitochondria in muscle has not been widely studied during the development of HD. To determine the role of mitochondria in skeletal muscle during the early stages of HD, we analyzed quadriceps femoris muscle from 24-, 36-, 48- and 66-month-old transgenic minipigs that expressed the N-terminal portion of mutated human huntingtin protein (TgHD) and age-matched wild-type (WT) siblings. We found altered ultrastructure of TgHD muscle tissue and mitochondria. There was also significant reduction of activity of citrate synthase and respiratory chain complexes (RCCs) I, II and IV, decreased quantity of oligomycin-sensitivity conferring protein (OSCP) and the E2 subunit of pyruvate dehydrogenase (PDHE2), and differential expression of optic atrophy 1 protein (OPA1) and dynamin-related protein 1 (DRP1) in the skeletal muscle of TgHD minipigs. Statistical analysis identified several parameters that were dependent only on HD status and could therefore be used as potential biomarkers of disease progression. In particular, the reduction of biomarker RCCII subunit SDH30 quantity suggests that similar pathogenic mechanisms underlie disease progression in TgHD minipigs and HD patients. The perturbed biochemical phenotype was detectable in TgHD minipigs prior to the development of ultrastructural changes and locomotor impairment, which become evident at the age of 48 months. Mitochondrial disturbances may contribute to energetic depression in skeletal muscle in HD, which is in concordance with the mobility problems observed in this model.This article has an associated First Person interview with the first author of the paper.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a geneticky modifikovaná zvířata $7 D030801
- 650 _2
- $a tělesná hmotnost $7 D001835
- 650 _2
- $a DNA $x metabolismus $7 D004247
- 650 12
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a transport elektronů $7 D004579
- 650 12
- $a energetický metabolismus $7 D004734
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a protein huntingtin $x genetika $7 D000071058
- 650 _2
- $a Huntingtonova nemoc $x metabolismus $x patologie $7 D006816
- 650 _2
- $a svalové mitochondrie $x metabolismus $x ultrastruktura $7 D008931
- 650 _2
- $a mitochondriální proteiny $x metabolismus $7 D024101
- 650 _2
- $a kosterní svaly $x metabolismus $x ultrastruktura $7 D018482
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a oxidativní fosforylace $7 D010085
- 650 _2
- $a prasata $7 D013552
- 650 _2
- $a miniaturní prasata $7 D013556
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Krizova, Jana $u Laboratory for Study of Mitochondrial Disorders, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12108 Prague 2, Czech Republic.
- 700 1_
- $a Stufkova, Hana $u Laboratory for Study of Mitochondrial Disorders, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12108 Prague 2, Czech Republic.
- 700 1_
- $a Bohuslavova, Bozena $u Laboratory of Cell Regeneration and Cell Plasticity, Institute of Animal Physiology and Genetics AS CR, 27721 Liběchov, Czech Republic.
- 700 1_
- $a Askeland, Georgina $u Department of Medical Biochemistry, University of Oslo and Oslo University Hospital, 0372 Oslo, Norway.
- 700 1_
- $a Dosoudilova, Zaneta $u Laboratory for Study of Mitochondrial Disorders, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12108 Prague 2, Czech Republic.
- 700 1_
- $a Juhas, Stefan $u Laboratory of Cell Regeneration and Cell Plasticity, Institute of Animal Physiology and Genetics AS CR, 27721 Liběchov, Czech Republic.
- 700 1_
- $a Juhasova, Jana $u Laboratory of Cell Regeneration and Cell Plasticity, Institute of Animal Physiology and Genetics AS CR, 27721 Liběchov, Czech Republic.
- 700 1_
- $a Ellederova, Zdenka $u Laboratory of Cell Regeneration and Cell Plasticity, Institute of Animal Physiology and Genetics AS CR, 27721 Liběchov, Czech Republic.
- 700 1_
- $a Zeman, Jiri $u Laboratory for Study of Mitochondrial Disorders, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12108 Prague 2, Czech Republic.
- 700 1_
- $a Eide, Lars $u Department of Medical Biochemistry, University of Oslo and Oslo University Hospital, 0372 Oslo, Norway.
- 700 1_
- $a Motlik, Jan $u Laboratory of Cell Regeneration and Cell Plasticity, Institute of Animal Physiology and Genetics AS CR, 27721 Liběchov, Czech Republic.
- 700 1_
- $a Hansikova, Hana $u Laboratory for Study of Mitochondrial Disorders, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12108 Prague 2, Czech Republic hana.hansikova@lf1.cuni.cz.
- 773 0_
- $w MED00173721 $t Disease models & mechanisms $x 1754-8411 $g Roč. 12, č. 7 (2019)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31278192 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201214131255 $b ABA008
- 999 __
- $a ok $b bmc $g 1596127 $s 1114484
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 12 $c 7 $e 20190726 $i 1754-8411 $m Disease models & mechanisms $n Dis Model Mech $x MED00173721
- LZP __
- $a Pubmed-20201125